Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 180 of 180 entries
Sorted by: Best Match Show Resources per page
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network.

Acta Cardiologica Sinica

Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Dei Cas L, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, J Filipiak K, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF.
PMID: 28630534
Acta Cardiol Sin. 2017 May;33(3):315-322.

The International Committee of Medical Journal Editors (ICMJE) provides recommendations to improve the editorial standards and scientific quality of biomedical journals. These recommendations range from uniform technical requirements to more complex and elusive editorial issues including ethical aspects of...

Cite
Alfonso F, Adamyan K, Artigou JY, et al. Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. Acta Cardiol Sin. 2017;33(3):315-322
Alfonso, F., Adamyan, K., Artigou, J. Y., Aschermann, M., Boehm, M., Buendia, A., Chu, P. H., Cohen, A., Dei Cas, L., Dilic, M., Doubell, A., Echeverri, D., Enç, N., Ferreira-González, I., J Filipiak, K., Flammer, A., Fleck, E., Gatzov, P., Ginghina, C., Goncalves, L., Haouala, H., Hassanein, M., Heusch, G., Huber, K., Hulín, I., Ivanusa, M., Krittayaphong, R., Lau, C. P., Marinskis, G., Mach, F., Moreira, L. F., Nieminen, T., Oukerraj, L., Perings, S., Pierard, L., Potpara, T., Reyes-Caorsi, W., Rim, S. J., Rødevand, O., Saade, G., Sander, M., Shlyakhto, E., Timuralp, B., Tousoulis, D., Ural, D., Piek, J. J., Varga, A., & Lüscher, T. F. (2017). Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. Acta Cardiologica Sinica, 33(3), 315-322.
Alfonso, Fernando, et al. "Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network." Acta Cardiologica Sinica vol. 33,3 (2017): 315-322.
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Dei Cas L, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, J Filipiak K, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. Acta Cardiol Sin. 2017 May;33(3):315-322. PMID: 28630534; PMCID: PMC5465387.
Copy Download .nbib Format: NLM
Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion.

Journal of the renin-angiotensin-aldosterone system : JRAAS

Schulz R, Heusch G.
PMID: 28095247
J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1):S136-S140. doi: 10.1177/14703203010020012401.

No abstract available.

Cite
Schulz R, Heusch G. Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion. J Renin Angiotensin Aldosterone Syst. 2001;2(1):S136-S140doi: 10.1177/14703203010020012401.
Schulz, R., & Heusch, G. (2001). Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2(1), S136-S140. https://doi.org/10.1177/14703203010020012401
Schulz, Rainer, and Heusch, Gerd. "Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion." Journal of the renin-angiotensin-aldosterone system : JRAAS vol. 2,1 (2001): S136-S140. doi: https://doi.org/10.1177/14703203010020012401
Schulz R, Heusch G. Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion. J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1):S136-S140. doi: 10.1177/14703203010020012401. PMID: 28095247.
Copy Download .nbib Format: NLM
Morphologic and Functional Imaging of Non-Colorectal Liver Metastases.

Viszeralmedizin

Heusch P, Antoch G.
PMID: 26889141
Viszeralmedizin. 2015 Dec;31(6):387-92. doi: 10.1159/000441857. Epub 2015 Nov 23.

Liver metastases are the most frequent malignant liver lesions. Besides colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, breast cancer, lung cancer, and neuroendocrine tumors are the most common entities that metastasize to the liver. The morphology of these metastases depends...

Cite
Heusch P, Antoch G. Morphologic and Functional Imaging of Non-Colorectal Liver Metastases. Viszeralmedizin. 2015;31(6):387-92doi: 10.1159/000441857.
Heusch, P., & Antoch, G. (2015). Morphologic and Functional Imaging of Non-Colorectal Liver Metastases. Viszeralmedizin, 31(6), 387-92. https://doi.org/10.1159/000441857
Heusch, Philipp, and Antoch, Gerald. "Morphologic and Functional Imaging of Non-Colorectal Liver Metastases." Viszeralmedizin vol. 31,6 (2015): 387-92. doi: https://doi.org/10.1159/000441857
Heusch P, Antoch G. Morphologic and Functional Imaging of Non-Colorectal Liver Metastases. Viszeralmedizin. 2015 Dec;31(6):387-92. doi: 10.1159/000441857. Epub 2015 Nov 23. PMID: 26889141; PMCID: PMC4748792.
Copy Download .nbib Format: NLM
Authorship: From credit to accountability - Reflections from the Editors' network.

Archivos de cardiologia de Mexico

Alfonso F, Zelveian P, Monsuez JJ, Aschermann M, Boehm M, Buendía-Hernández A, Wang TD, Cohen A, Izetbegovic S, Doubell A, Echeverri D, Enç N, Ferreira-González I, Undas A, Fortmüller U, Gatzov P, Ginghina C, Goncalves L, Addad F, Hassanein M, Heusch G, Huber K, Hatala R, Ivanusa M, Lau CP, Marinskis G, Dei-Cas L, Rochitte CE, Nikus K, Fleck E, Pierard L, Obradović S, Aguilar-Passano MDP, Jang Y, Rødevand O, Sander M, Shlyakhto E, Erol Ç, Tousoulis D, Ural D, Piek JJ, Varga A, Mach AJF, Dibra A, Guliyev F, Mrochek A, Rogava M, Guzmán-Melgar I, Pasquale GD, Kabdrakhmanov K, Haddour L, Fras Z, Held C, Shumakov V.
PMID: 31314006
Arch Cardiol Mex. 2019;89(2):105-111. doi: 10.24875/ACM.M19000044.

The Editors' Network of the European Society of Cardiology (ESC) provides a dynamic forum for editorial discussions and endorses the recommendations of the International Committee of Medical Journal Editors (ICMJE) to improve the scientific quality of biomedical journals. Authorship...

Cite
Alfonso F, Zelveian P, Monsuez JJ, et al. Authorship: From credit to accountability - Reflections from the Editors' network. Arch Cardiol Mex. 2019;89(2):105-111doi: 10.24875/ACM.M19000044.
Alfonso, F., Zelveian, P., Monsuez, J. J., Aschermann, M., Boehm, M., Buendía-Hernández, A., Wang, T. D., Cohen, A., Izetbegovic, S., Doubell, A., Echeverri, D., Enç, N., Ferreira-González, I., Undas, A., Fortmüller, U., Gatzov, P., Ginghina, C., Goncalves, L., Addad, F., Hassanein, M., Heusch, G., Huber, K., Hatala, R., Ivanusa, M., Lau, C. P., Marinskis, G., Dei-Cas, L., Rochitte, C. E., Nikus, K., Fleck, E., Pierard, L., Obradović, S., Aguilar-Passano, M. D. P., Jang, Y., Rødevand, O., Sander, M., Shlyakhto, E., Erol, �. �., Tousoulis, D., Ural, D., Piek, J. J., Varga, A., Mach, A. J. F., Dibra, A., Guliyev, F., Mrochek, A., Rogava, M., Guzmán-Melgar, I., Pasquale, G. D., Kabdrakhmanov, K., Haddour, L., Fras, Z., Held, C., & Shumakov, V. (2019). Authorship: From credit to accountability - Reflections from the Editors' network. Archivos de cardiologia de Mexico, 89(2), 105-111. https://doi.org/10.24875/ACM.M19000044
Alfonso, Fernando, et al. "Authorship: From credit to accountability - Reflections from the Editors' network." Archivos de cardiologia de Mexico vol. 89,2 (2019): 105-111. doi: https://doi.org/10.24875/ACM.M19000044
Alfonso F, Zelveian P, Monsuez JJ, Aschermann M, Boehm M, Buendía-Hernández A, Wang TD, Cohen A, Izetbegovic S, Doubell A, Echeverri D, Enç N, Ferreira-González I, Undas A, Fortmüller U, Gatzov P, Ginghina C, Goncalves L, Addad F, Hassanein M, Heusch G, Huber K, Hatala R, Ivanusa M, Lau CP, Marinskis G, Dei-Cas L, Rochitte CE, Nikus K, Fleck E, Pierard L, Obradović S, Aguilar-Passano MDP, Jang Y, Rødevand O, Sander M, Shlyakhto E, Erol Ç, Tousoulis D, Ural D, Piek JJ, Varga A, Mach AJF, Dibra A, Guliyev F, Mrochek A, Rogava M, Guzmán-Melgar I, Pasquale GD, Kabdrakhmanov K, Haddour L, Fras Z, Held C, Shumakov V. Authorship: From credit to accountability - Reflections from the Editors' network. Arch Cardiol Mex. 2019;89(2):105-111. doi: 10.24875/ACM.M19000044. PMID: 31314006.
Copy Download .nbib Format: NLM
Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2.

Human molecular genetics

Pott J, Gadin J, Theusch E, Kleber ME, Delgado GE, Kirsten H, Hauck SM, Burkhardt R, Scharnagl H, Krauss RM, Loeffler M, März W, Thiery J, Silveira A, Vant Hooft FM, Scholz M.
PMID: 34590679
Hum Mol Genet. 2021 Sep 30; doi: 10.1093/hmg/ddab279. Epub 2021 Sep 30.

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key player in lipid metabolism, as it degrades LDL receptors from hepatic cell membranes. So far, only variants of the PCSK9 gene locus were found to be associated with PCSK9...

Cite
Pott J, Gadin J, Theusch E, et al. Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2. Hum Mol Genet. 2021;doi: 10.1093/hmg/ddab279.
Pott, J., Gadin, J., Theusch, E., Kleber, M. E., Delgado, G. E., Kirsten, H., Hauck, S. M., Burkhardt, R., Scharnagl, H., Krauss, R. M., Loeffler, M., März, W., Thiery, J., Silveira, A., Vant Hooft, F. M., & Scholz, M. (2021). Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2. Human molecular genetics, . https://doi.org/10.1093/hmg/ddab279
Pott, Janne, et al. "Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2." Human molecular genetics vol. (2021). doi: https://doi.org/10.1093/hmg/ddab279
Pott J, Gadin J, Theusch E, Kleber ME, Delgado GE, Kirsten H, Hauck SM, Burkhardt R, Scharnagl H, Krauss RM, Loeffler M, März W, Thiery J, Silveira A, Vant Hooft FM, Scholz M. Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2. Hum Mol Genet. 2021 Sep 30; doi: 10.1093/hmg/ddab279. Epub 2021 Sep 30. PMID: 34590679.
Copy Download .nbib Format: NLM
Formation of phenylacetylene and benzocyclobutadiene in the .

Physical chemistry chemical physics : PCCP

McCabe MN, Hemberger P, Campisi D, Broxterman JC, Reusch E, Bodi A, Bouwman J.
PMID: 34989380
Phys Chem Chem Phys. 2022 Jan 06; doi: 10.1039/d1cp05183k. Epub 2022 Jan 06.

No abstract available.

Cite
McCabe MN, Hemberger P, Campisi D, et al. Formation of phenylacetylene and benzocyclobutadiene in the . Phys Chem Chem Phys. 2022;doi: 10.1039/d1cp05183k.
McCabe, M. N., Hemberger, P., Campisi, D., Broxterman, J. C., Reusch, E., Bodi, A., & Bouwman, J. (2022). Formation of phenylacetylene and benzocyclobutadiene in the . Physical chemistry chemical physics : PCCP, . https://doi.org/10.1039/d1cp05183k
McCabe, Morgan N, et al. "Formation of phenylacetylene and benzocyclobutadiene in the ." Physical chemistry chemical physics : PCCP vol. (2022). doi: https://doi.org/10.1039/d1cp05183k
McCabe MN, Hemberger P, Campisi D, Broxterman JC, Reusch E, Bodi A, Bouwman J. Formation of phenylacetylene and benzocyclobutadiene in the . Phys Chem Chem Phys. 2022 Jan 06; doi: 10.1039/d1cp05183k. Epub 2022 Jan 06. PMID: 34989380.
Copy Download .nbib Format: NLM
Femtosecond dynamics of diphenylpropynylidene in ethanol and dichloromethane.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Ress L, Kaiser D, Grüne J, Gerlach M, Reusch E, Brixner T, Sperlich A, Engels B, Fischer I.
PMID: 33740753
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Jun 05;254:119606. doi: 10.1016/j.saa.2021.119606. Epub 2021 Feb 27.

Carbon chains with an odd number of C atoms are reactive intermediates with a high biradical character. Here we report a joint experimental and computational investigation of the dynamics of diphenylpropynylidene, C

Cite
Ress L, Kaiser D, Grüne J, et al. Femtosecond dynamics of diphenylpropynylidene in ethanol and dichloromethane. Spectrochim Acta A Mol Biomol Spectrosc. 2021;254:119606doi: 10.1016/j.saa.2021.119606.
Ress, L., Kaiser, D., Grüne, J., Gerlach, M., Reusch, E., Brixner, T., Sperlich, A., Engels, B., & Fischer, I. (2021). Femtosecond dynamics of diphenylpropynylidene in ethanol and dichloromethane. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 254119606. https://doi.org/10.1016/j.saa.2021.119606
Ress, Lea, et al. "Femtosecond dynamics of diphenylpropynylidene in ethanol and dichloromethane." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 254 (2021): 119606. doi: https://doi.org/10.1016/j.saa.2021.119606
Ress L, Kaiser D, Grüne J, Gerlach M, Reusch E, Brixner T, Sperlich A, Engels B, Fischer I. Femtosecond dynamics of diphenylpropynylidene in ethanol and dichloromethane. Spectrochim Acta A Mol Biomol Spectrosc. 2021 Jun 05;254:119606. doi: 10.1016/j.saa.2021.119606. Epub 2021 Feb 27. PMID: 33740753.
Copy Download .nbib Format: NLM
A pathophysiological compass to personalize antianginal drug treatment.

Nature reviews. Cardiology

Bertero E, Heusch G, Münzel T, Maack C.
PMID: 34234310
Nat Rev Cardiol. 2021 Dec;18(12):838-852. doi: 10.1038/s41569-021-00573-w. Epub 2021 Jul 07.

Myocardial ischaemia results from coronary macrovascular or microvascular dysfunction compromising the supply of oxygen and nutrients to the myocardium. The underlying pathophysiological processes are manifold and encompass atherosclerosis of epicardial coronary arteries, vasospasm of large or small vessels and...

Cite
Bertero E, Heusch G, Münzel T, et al. A pathophysiological compass to personalize antianginal drug treatment. Nat Rev Cardiol. 2021;18(12):838-852doi: 10.1038/s41569-021-00573-w.
Bertero, E., Heusch, G., Münzel, T., & Maack, C. (2021). A pathophysiological compass to personalize antianginal drug treatment. Nature reviews. Cardiology, 18(12), 838-852. https://doi.org/10.1038/s41569-021-00573-w
Bertero, Edoardo, et al. "A pathophysiological compass to personalize antianginal drug treatment." Nature reviews. Cardiology vol. 18,12 (2021): 838-852. doi: https://doi.org/10.1038/s41569-021-00573-w
Bertero E, Heusch G, Münzel T, Maack C. A pathophysiological compass to personalize antianginal drug treatment. Nat Rev Cardiol. 2021 Dec;18(12):838-852. doi: 10.1038/s41569-021-00573-w. Epub 2021 Jul 07. PMID: 34234310.
Copy Download .nbib Format: NLM
Cardiac PET/MRI-an update.

European journal of hybrid imaging

Rischpler C, Nekolla SG, Heusch G, Umutlu L, Rassaf T, Heusch P, Herrmann K, Nensa F.
PMID: 34191143
Eur J Hybrid Imaging. 2019 Jan 22;3(1):2. doi: 10.1186/s41824-018-0050-2.

It is now about 8 years since the first whole-body integrated PET/MRI has been installed. First, reports on technical characteristics and system performance were published. Early after, reports on the first use of PET/MRI in oncological patients were released....

Cite
Rischpler C, Nekolla SG, Heusch G, et al. Cardiac PET/MRI-an update. Eur J Hybrid Imaging. 2019;3(1):2doi: 10.1186/s41824-018-0050-2.
Rischpler, C., Nekolla, S. G., Heusch, G., Umutlu, L., Rassaf, T., Heusch, P., Herrmann, K., & Nensa, F. (2019). Cardiac PET/MRI-an update. European journal of hybrid imaging, 3(1), 2. https://doi.org/10.1186/s41824-018-0050-2
Rischpler, C, et al. "Cardiac PET/MRI-an update." European journal of hybrid imaging vol. 3,1 (2019): 2. doi: https://doi.org/10.1186/s41824-018-0050-2
Rischpler C, Nekolla SG, Heusch G, Umutlu L, Rassaf T, Heusch P, Herrmann K, Nensa F. Cardiac PET/MRI-an update. Eur J Hybrid Imaging. 2019 Jan 22;3(1):2. doi: 10.1186/s41824-018-0050-2. PMID: 34191143; PMCID: PMC8212244.
Copy Download .nbib Format: NLM
Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations.

Blood

Cramer P, Tausch E, von Tresckow J, Giza A, Robrecht S, Schneider C, Fürstenau M, Langerbeins P, Al-Sawaf O, Pelzer BW, Fink AM, Fischer K, Wendtner CM, Eichhorst B, Kneba M, Stilgenbauer S, Hallek M.
PMID: 34086865
Blood. 2021 Nov 11;138(19):1805-1816. doi: 10.1182/blood.2020010484.

Fifty-one of 189 evaluable patients from 3 prospective phase 2 trials evaluating a sequential targeted treatment had high-risk chronic lymphocytic leukemia (CLL) with a 17p deletion, TP53 mutation, or both. Twenty-seven patients started treatment with bendamustine debulking before induction...

Cite
Cramer P, Tausch E, von Tresckow J, et al. Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations. Blood. 2021;138(19):1805-1816doi: 10.1182/blood.2020010484.
Cramer, P., Tausch, E., von Tresckow, J., Giza, A., Robrecht, S., Schneider, C., Fürstenau, M., Langerbeins, P., Al-Sawaf, O., Pelzer, B. W., Fink, A. M., Fischer, K., Wendtner, C. M., Eichhorst, B., Kneba, M., Stilgenbauer, S., & Hallek, M. (2021). Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations. Blood, 138(19), 1805-1816. https://doi.org/10.1182/blood.2020010484
Cramer, Paula, et al. "Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations." Blood vol. 138,19 (2021): 1805-1816. doi: https://doi.org/10.1182/blood.2020010484
Cramer P, Tausch E, von Tresckow J, Giza A, Robrecht S, Schneider C, Fürstenau M, Langerbeins P, Al-Sawaf O, Pelzer BW, Fink AM, Fischer K, Wendtner CM, Eichhorst B, Kneba M, Stilgenbauer S, Hallek M. Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations. Blood. 2021 Nov 11;138(19):1805-1816. doi: 10.1182/blood.2020010484. PMID: 34086865.
Copy Download .nbib Format: NLM
Coronary blood flow in heart failure: cause, consequence and bystander.

Basic research in cardiology

Heusch G.
PMID: 35024969
Basic Res Cardiol. 2022 Jan 13;117(1):1. doi: 10.1007/s00395-022-00909-8.

Heart failure is a clinical syndrome where cardiac output is not sufficient to sustain adequate perfusion and normal bodily functions, initially during exercise and in more severe forms also at rest. The two most frequent forms are heart failure...

Cite
Heusch G. Coronary blood flow in heart failure: cause, consequence and bystander. Basic Res Cardiol. 2022;117(1):1doi: 10.1007/s00395-022-00909-8.
Heusch, G. (2022). Coronary blood flow in heart failure: cause, consequence and bystander. Basic research in cardiology, 117(1), 1. https://doi.org/10.1007/s00395-022-00909-8
Heusch, Gerd. "Coronary blood flow in heart failure: cause, consequence and bystander." Basic research in cardiology vol. 117,1 (2022): 1. doi: https://doi.org/10.1007/s00395-022-00909-8
Heusch G. Coronary blood flow in heart failure: cause, consequence and bystander. Basic Res Cardiol. 2022 Jan 13;117(1):1. doi: 10.1007/s00395-022-00909-8. PMID: 35024969.
Copy Download .nbib Format: NLM
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.

Blood

Langerbeins P, Zhang C, Robrecht S, Cramer P, Fürstenau M, Al-Sawaf O, von Tresckow J, Fink AM, Kreuzer KA, Vehling-Kaiser U, Tausch E, Müller L, Eckart MJ, Schlag R, Freier W, Gaska T, Balser C, Reiser M, Stauch M, Wendtner CM, Fischer K, Stilgenbauer S, Eichhorst B, Hallek M.
PMID: 34758069
Blood. 2022 Jan 13;139(2):177-187. doi: 10.1182/blood.2021010845.

Observation is the current standard of care for patients with early-stage asymptomatic chronic lymphocytic leukemia (CLL), as chemotherapy-based interventions have failed to prolong survival. We hypothesized that early intervention with ibrutinib would be well tolerated and lead to superior...

Cite
Langerbeins P, Zhang C, Robrecht S, et al. The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia. Blood. 2022;139(2):177-187doi: 10.1182/blood.2021010845.
Langerbeins, P., Zhang, C., Robrecht, S., Cramer, P., Fürstenau, M., Al-Sawaf, O., von Tresckow, J., Fink, A. M., Kreuzer, K. A., Vehling-Kaiser, U., Tausch, E., Müller, L., Eckart, M. J., Schlag, R., Freier, W., Gaska, T., Balser, C., Reiser, M., Stauch, M., Wendtner, C. M., Fischer, K., Stilgenbauer, S., Eichhorst, B., & Hallek, M. (2022). The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia. Blood, 139(2), 177-187. https://doi.org/10.1182/blood.2021010845
Langerbeins, Petra, et al. "The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia." Blood vol. 139,2 (2022): 177-187. doi: https://doi.org/10.1182/blood.2021010845
Langerbeins P, Zhang C, Robrecht S, Cramer P, Fürstenau M, Al-Sawaf O, von Tresckow J, Fink AM, Kreuzer KA, Vehling-Kaiser U, Tausch E, Müller L, Eckart MJ, Schlag R, Freier W, Gaska T, Balser C, Reiser M, Stauch M, Wendtner CM, Fischer K, Stilgenbauer S, Eichhorst B, Hallek M. The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia. Blood. 2022 Jan 13;139(2):177-187. doi: 10.1182/blood.2021010845. PMID: 34758069.
Copy Download .nbib Format: NLM
Showing 169 to 180 of 180 entries